Next Article in Journal
Experimental Characterization of the Thermal Conductivity and Microstructure of Opacifier-Fiber-Aerogel Composite
Next Article in Special Issue
Resveratrol Suppresses Matrix Metalloproteinase-2 Activation Induced by Lipopolysaccharide in Mouse Osteoblasts via Interactions with AMP-Activated Protein Kinase and Suppressor of Cytokine Signaling 1
Previous Article in Journal
Photochemical and Structural Studies on Cyclic Peptide Models
Previous Article in Special Issue
Synergistic Effects of Resveratrol and Pyrimethanil against Botrytis cinerea on Grape
Review

Resveratrol and Depression in Animal Models: A Systematic Review of the Biological Mechanisms

School of Exercise and Nutritional Sciences, San Diego State University, San Diego, CA 92182, USA
*
Author to whom correspondence should be addressed.
Molecules 2018, 23(9), 2197; https://doi.org/10.3390/molecules23092197
Received: 30 July 2018 / Revised: 25 August 2018 / Accepted: 28 August 2018 / Published: 30 August 2018
(This article belongs to the Collection Phytoalexins: Fundamental Aspects and Applications)
Depression is currently treated by pharmacotherapies that can elicit debilitating side effects for patients. Novel treatment options with limited side effects are currently being researched. Resveratrol is a polyphenol and phytoalexin found in the skins of grapes, red wine, Japanese knotweed, and peanuts. It has been studied extensively for its antioxidant and anti-inflammatory properties. Resveratrol has also gained attention for its neuroprotective properties. The aim of the review was to examine the mechanisms by which resveratrol reduces depressive behaviors in animal models. In total, 22 studies met the established criteria for final review. Behavioral aspects of depression were investigated using validated measures such as the forced swimming test, tail suspension test, sucrose preference test, and open field test. While many physical measures were taken, three main biological mechanisms were explored: Regulation of the hypothalamic–pituitary–adrenal axis; decreased inflammation; and increased Brain-Derived Neurotrophic Factor and neurogenesis. Based on these findings, resveratrol may be deemed an effective treatment for depression in animal models at doses between 10–80 mg/kg/day, although higher doses had the most significant effects. Future studies should examine the effects of resveratrol on depression in humans to determine the eligibility of resveratrol as a natural antidepressant with less severe side effects. View Full-Text
Keywords: resveratrol; depression; anxiety; stress; neurogenesis; BDNF; inflammation resveratrol; depression; anxiety; stress; neurogenesis; BDNF; inflammation
Show Figures

Figure 1

MDPI and ACS Style

Moore, A.; Beidler, J.; Hong, M.Y. Resveratrol and Depression in Animal Models: A Systematic Review of the Biological Mechanisms. Molecules 2018, 23, 2197. https://doi.org/10.3390/molecules23092197

AMA Style

Moore A, Beidler J, Hong MY. Resveratrol and Depression in Animal Models: A Systematic Review of the Biological Mechanisms. Molecules. 2018; 23(9):2197. https://doi.org/10.3390/molecules23092197

Chicago/Turabian Style

Moore, Alyssa, Joshua Beidler, and Mee Y. Hong. 2018. "Resveratrol and Depression in Animal Models: A Systematic Review of the Biological Mechanisms" Molecules 23, no. 9: 2197. https://doi.org/10.3390/molecules23092197

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop